40 results on '"Schlack A"'
Search Results
2. ADHD in children and adolescents: Guideline-based online assessment in the consortium project INTEGRATE-ADHD
3. When do parents report their child’s administrative ADHD diagnosis? A utilisation-based analysis from the consortium project INTEGRATE-ADHD
4. Differences in frequency between administrative and parent-reported ADHD diagnosis data of children and adolescents taking sociodemographic characteristics into account – Results from the consortium project INTEGRATE-ADHD
5. Health care costs of incident ADHD in children and adolescents in Germany – A claims data analysis within the framework of the consortium project INTEGRATE-ADHD
6. Psychometric evaluation of the Clinical Interview for Externalizing Disorders (ILF-EXTERNAL) in an online setting – Results from the consortium project INTEGRATE-ADHD
7. Risk and protective factors associated with health-related quality of life in children and adolescents with ADHD in Germany – Findings from the consortium project INTEGRATE-ADHD
8. Prevalence of child maltreatment in a nationwide sample of 18 to 31 year-olds in Germany
9. An optogenetic method for the controlled release of single molecules
10. Elterliches Belastungserleben, Unaufmerksamkeits‑/Hyperaktivitätssymptome und elternberichtete ADHS bei Kindern und Jugendlichen: Ergebnisse aus der KiGGS-Studie
11. Establishment of primary prostate epithelial and tumorigenic cell lines using a non-viral immortalization approach
12. Adhesion energy controls lipid binding-mediated endocytosis
13. A societal challenge with high public health relevance: ADHD in children and adolescents in Germany
14. Establishment of primary prostate epithelial and tumorigenic cell lines using a non-viral immortalization approach
15. Enhancing Biomarker Detection in Cancer: A Comparative Analysis of Preanalytical Reverse Transcription Enzymes for Liquid Biopsy Application
16. Immune-Related Adverse Events Can Predict Progression-Free and Overall Survival In Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors
17. Persistent Barriers of the Gluten-Free Basic Food Basket: Availability, Cost, and Nutritional Composition Assessment
18. Subgroup analysis of real-world efficacy of enfortumab vedotin in patients with metastatic/locally advanced urothelial carcinoma from a European database.
19. Early treatment response assessment with [177Lu]PSMA whole-body-scintigraphy compared to interim PSMA-PET.
20. Prevalence of child maltreatment in a nationwide sample of 18 to 31 year-olds in Germany.
21. Notfälle in der Medikamentösen Tumortherapie.
22. Cabozantinib Plus Nivolumab in Adult Patients with Advanced or Metastatic Renal Cell Carcinoma: A Retrospective, Non-Interventional Study in a Real-World Cohort/GUARDIANS Project.
23. NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer
24. Adhesion energy controls lipid binding-mediated endocytosis
25. Persistent Barriers of the Gluten-Free Basic Food Basket: Availability, Cost, and Nutritional Composition Assessment
26. Breaking boundaries: Exploring extended pembrolizumab in first-line treatment of renal cell carcinoma with axitinib-pembrolizumab combination
27. Disrupted degradative sorting of TLR7 is associated with human lupus
28. Sunitinib for metastatic renal cell carcinoma: Real world data from the STAR-TOR registry and detailed literature review
29. Utomhusmiljöns meningserbjudanen : En tematisk observationsstudie om vilka meningserbjudanden barnen plockar upp i förskolans utomhusmiljö
30. INTEGRATE-ADHD: Vergleich und Integration administrativer und epidemiologischer ADHS-Diagnosedaten durch klinisches Assessment – Vorstellung des Projekts.
31. Occurrence of NECTIN4 amplification in solid tumors and enfortumab vedotin response in metastatic urothelial cancer.
32. Safety and efficacy of enfortumab vedotin in patients with metastatic/locally advanced urothelial cancer: Real-world evidence from a European database.
33. Real-world treatment (tx) patterns and clinical outcomes in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) in Germany: Results of a retrospective observational study (CONVINCE).
34. Breaking boundaries: Exploring extended pembrolizumab in first-line treatment of renal cell carcinoma with axitinib-pembrolizumab combination.
35. Systemic and surgical treatment in renal cell carcinoma: Does timing matter?
36. Real world evidence from a retrospective multi-center analysis on first-line therapy for metastatic renal cell carcinoma with non-clear cell and/or sarcomatoid histologies.
37. Treatment options and outcome of patients with metastatic renal cell carcinoma with brain or bone metastases: Real world evidence from a German retrospective multi-center analysis.
38. Der Global-Index der Conners-Skalen
39. Expert Consensus Recommendations on the Management of Treatment-emergent Adverse Events Among Men with Prostate Cancer Taking Poly-ADP Ribose Polymerase Inhibitor + Novel Hormonal Therapy Combination Therapy
40. A0837 - Breaking boundaries: Exploring extended pembrolizumab in first-line treatment of renal cell carcinoma with axitinib-pembrolizumab combination.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.